Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)

Anthony A. Bavry, Dharam J. Kumbhani, Thomas J. Helton, Deepak L. Bhatt

Research output: Contribution to journalArticle

66 Scopus citations

Abstract

We conducted a meta-analysis on 6 studies in 2,963 patients who had coronary artery disease and received a sirolimus-eluting stent or a bare metal stent for revascularization. Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95% confidence interval 0.22 to 1.12, p = 0.09).

Original languageEnglish (US)
Pages (from-to)1469-1472
Number of pages4
JournalAmerican Journal of Cardiology
Volume95
Issue number12
DOIs
StatePublished - Jun 15 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)'. Together they form a unique fingerprint.

  • Cite this